Dr. Ricardo A. Barzaga, MD

Dr. Barzaga practices at Southern Ocean Medical Center in Manahawkin, New Jersey, part of Hackensack Meridian Health.

Dr. Barzaga's NPI, 1922044759, was assigned on June 21, 2006. Dr. Barzaga holds New Jersey license 25MA05236900.

Dr. Barzaga's primary practice is Southern Ocean Medical Center, at 1140 Rt 72 W, Manahawkin, NJ 08050 in Ocean County. The practice phone is (609) 597-6011. Dr. Barzaga also practices at Southern Ocean Medical Center, 1301 State Highway 72, Manahawkin, NJ 08050.

Dr. Barzaga's primary practice is Southern Ocean Medical Center in Manahawkin, New Jersey, part of Hackensack Meridian Health. Dr. Barzaga is also affiliated with Jersey Shore University Medical Center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Barzaga practices, 2 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Barzaga's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Barzaga is licensed in New Jersey.

CMS data shows 510 Medicare services from Dr. Barzaga across 4 procedure codes in 2024, for 162 Medicare patients. Medicare paid $35,475 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 162 Medicare patients who saw Dr. Barzaga in 2024. The largest group is 75 to 84, with 59 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 2.89, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Barzaga's median patient age at 73, with 36% women.

In 2024, Dr. Barzaga wrote 13 Medicare Part D claims. They cover 2 drugs, with $6,935 in total drug cost. In 2019, CMS named 16 claims across 1 drug.

Dr. Barzaga accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 125 general payments to Dr. Barzaga from 9 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 88% of the total. Abbvie Inc. paid the most, $1,106.